Literature DB >> 16035670

The possible role of radiofrequency as complementary treatment of locally advanced gastric cancer.

A Carditello1, C Scisca, F Stilo, A Parisi, M Basile.   

Abstract

AIM: The prognosis of locally advanced gastric cancer (T3-T4) is bad. The presence of lymph nodes (N3-N4) or haematogenous metastases (liver, lung) gets worse the evolution; principally the hepatic malignancies are cause of scarce survival. The possible use of a palliative treatment as radiofrequency ablation (the good results are note about the treatment of hepatic malignancies by colo-rectal cancer) is reported in recent series. Therefore we decide to use radiofrequency ablation for the treatment of hepatic metastases by gastric cancer, difficulty treated surgically.
MATERIALS AND METHODS: From January 2001 to December 2002, 25 patients affected by hepatic metastases underwent to radiofrequency thermal ablation, 2 of them were affected by gastric adenocarcinoma. Case 1: A.P., 58 year-old man, one year before underwent to subtotal gastric resection according to Billroth II. After repeated postoperative chemotherapy cycles, he presented metastases at IV hepatic segment. The patient underwent to percutaneous radiofrequency ablation. The control CT scan confirmed metastasis disappearance. After three months, a partial recurrence was treated by the alcoholization. Three months after, we observed marked jaundice for multiple diffused metastases, followed by the exitus. Case 2: B.G., 63 year-old man, with advanced gastric adenocarcinoma (T4) at the pylorus and hepatic metastasis at IV segment. The patient underwent to gastrojejunostomy and to intraoperative radiofrequency ablation. Ultrasonography and CT scan controls were performed before discharge. The patient didn't undergo to successive controls. After 7 months, the patient returned with marked jaundice for diffused hepatic metastases; he refused any treatment, and then he died one month after.
CONCLUSIONS: Our preliminary results don't show complications related to the intra and peri-operative radiofrequency, with an important increase of the mean survival. The results, limited by poor experience, may indicate the complementary role of the radiofrequency in the palliative treatment of the hepatic metastases by advanced gastric cancer, difficulty treated surgically.

Entities:  

Mesh:

Year:  2005        PMID: 16035670

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  4 in total

Review 1.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

2.  Radiofrequency ablation for treating liver metastases from a non-colorectal origin.

Authors:  Bo La Yun; Jeong Min Lee; Ji Hyun Baek; Se Hyung Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2011-08-24       Impact factor: 3.500

3.  Prediction of T stage in gastric carcinoma by enhanced CT and oral contrast-enhanced ultrasonography.

Authors:  Tao Yu; Xinling Wang; Zilong Zhao; Fan Liu; Xiaoting Liu; Yan Zhao; Yahong Luo
Journal:  World J Surg Oncol       Date:  2015-05-19       Impact factor: 2.754

4.  Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma.

Authors:  Ji Yeong An; Je Yeon Kim; Min Gew Choi; Jae Hyung Noh; Dongil Choi; Tae Sung Sohn; Sung Kim
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.